Sih Partners, Lllp Biotechnology

Sih Partners, Lllp

$2.95 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$115B	$12.3 Billion 0.42% of portfolio	25,388	Q1 2025 New
REGN Regeneron Pharmaceuticals, Inc.	$55.5B	$4.92 Billion 0.17% of portfolio	7,750	Q1 2025 New
BGNE Bei Gene, Ltd.	$23.5B	$2.28 Billion 0.08% of portfolio	8,371	Q1 2025 New
ALNY Alnylam Pharmaceuticals, Inc.	$37.4B	$2.15 Billion 0.07% of portfolio	7,959	Q1 2025 New
BNTX Bio N Tech Se	$26.4B	$1.46 Billion 0.05% of portfolio	16,041	Q1 2025 New
ARGX Argenx Se	$32.3B	$1.19 Billion 0.04% of portfolio	2,006	Q1 2025 New
MRNA Moderna, Inc.	$11B	$1.04 Billion 0.04% of portfolio	36,846	Q1 2025 New
SMMT Summit Therapeutics Inc.	$3.97B	$897 Million 0.03% of portfolio	46,492	Q1 2025 New
UTHR United Therapeutics Corp	$14.9B	$886 Million 0.03% of portfolio	2,875	Q1 2025 New
INSM Insmed Inc	$9.58B	$871 Million 0.03% of portfolio	11,415	Q1 2025 New
BMRN Biomarin Pharmaceutical Inc	$10.6B	$863 Million 0.03% of portfolio	12,209	Q1 2025 New
INCY Incyte Corp	$15.5B	$856 Million 0.03% of portfolio	14,135	Q1 2025 New
RPRX Royalty Pharma PLC	$14.6B	$837 Million 0.03% of portfolio	26,881	Q1 2025 New
EXEL Exelixis, Inc.	$13.8B	$646 Million 0.02% of portfolio	17,489	Q1 2025 New
ASND Ascendis Pharma A/S	$9.66B	$593 Million 0.02% of portfolio	3,807	Q1 2025 New
HALO Halozyme Therapeutics, Inc.	$7.57B	$487 Million 0.02% of portfolio	7,626	Q1 2025 New
JAZZ Jazz Pharmaceuticals PLC	$7.01B	$464 Million 0.02% of portfolio	3,739	Q1 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$4.69B	$461 Million 0.02% of portfolio	1,391	Q1 2025 New
ROIV Roivant Sciences Ltd.	$7.8B	$448 Million 0.02% of portfolio	44,403	Q1 2025 New
BBIO Bridge Bio Pharma, Inc.	$5.68B	$414 Million 0.01% of portfolio	11,974	Q1 2025 New
RVMD Revolution Medicines, Inc.	$3.56B	$414 Million 0.01% of portfolio	11,702	Q1 2025 New
SRPT Sarepta Therapeutics, Inc.	$3.48B	$374 Million 0.01% of portfolio	5,867	Q1 2025 New
IONS Ionis Pharmaceuticals Inc	$5.22B	$362 Million 0.01% of portfolio	11,999	Q1 2025 New
AXSM Axsome Therapeutics, Inc.	$4.71B	$358 Million 0.01% of portfolio	3,071	Q1 2025 New
BPMC Blueprint Medicines Corp	$7.64B	$356 Million 0.01% of portfolio	4,027	Q1 2025 New
CRSP Crispr Therapeutics Ag	$3.28B	$330 Million 0.01% of portfolio	9,712	Q1 2025 New
KRYS Krystal Biotech, Inc.	$3.49B	$327 Million 0.01% of portfolio	1,815	Q1 2025 New
PCVX Vaxcyte, Inc.	$2.21B	$306 Million 0.01% of portfolio	8,109	Q1 2025 New
VRNA Verona Pharma PLC	$5.08B	$302 Million 0.01% of portfolio	4,755	Q1 2025 New
NUVL Nuvalent, Inc.	$3.36B	$296 Million 0.01% of portfolio	4,169	Q1 2025 New
ADMA Adma Biologics, Inc.	$3.92B	$296 Million 0.01% of portfolio	14,897	Q1 2025 New
CYTK Cytokinetics Inc	$3.12B	$294 Million 0.01% of portfolio	7,307	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$825M	$271 Million 0.01% of portfolio	51,202	Q1 2025 New
PTCT Ptc Therapeutics, Inc.	$3.7B	$253 Million 0.01% of portfolio	4,962	Q1 2025 New
ACLX Arcellx, Inc.	$2.85B	$227 Million 0.01% of portfolio	3,461	Q1 2025 New
VCYT Veracyte, Inc.	$1.99B	$222 Million 0.01% of portfolio	7,500	Q1 2025 New
RNA Avidity Biosciences, Inc.	$1.86B	$222 Million 0.01% of portfolio	7,533	Q1 2025 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.66B	$211 Million 0.01% of portfolio	3,980	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$2.59B	$208 Million 0.01% of portfolio	5,738	Q1 2025 New
SWTX Spring Works Therapeutics, Inc.	$2.92B	$204 Million 0.01% of portfolio	4,628	Q1 2025 New
AKRO Akero Therapeutics, Inc.	$2.54B	$203 Million 0.01% of portfolio	5,018	Q1 2025 New
IMVT Immunovant, Inc.	$3.55B	$183 Million 0.01% of portfolio	10,705	Q1 2025 New
ACAD Acadia Pharmaceuticals Inc	$3.61B	$179 Million 0.01% of portfolio	10,756	Q1 2025 New
ADPT Adaptive Biotechnologies Corp	$1.41B	$164 Million 0.01% of portfolio	22,113	Q1 2025 New
FOLD Amicus Therapeutics, Inc.	$1.69B	$158 Million 0.01% of portfolio	19,364	Q1 2025 New
IBRX Immunity Bio, Inc.	$1.38B	$139 Million 0.0% of portfolio	46,017	Q1 2025 New
MNKD Mannkind Corp	$1.11B	$96.2 Million 0.0% of portfolio	19,132	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$629M	$95.3 Million 0.0% of portfolio	13,406	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$2.07B	$94.8 Million 0.0% of portfolio	12,639	Q1 2025 New
ABSI Absci Corp	$271M	$74.9 Million 0.0% of portfolio	29,836	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.